National Task Force recommends establishing 'India COVID-19 Clinical Research Collaborative Network'

Image
ANI General News
Last Updated : Apr 07 2020 | 10:40 PM IST

New Delhi [India], April 7 (ANI): Calling it an immediate priority, the National Task Force for COVID-19 has recommended establishing the "India COVID-19 Clinical Research Collaborative Network."

This will be coordinated by the Indian Council of Medical Research (ICMR). The goal of this network is to enhance the clinical understanding of COVID-19 in the country so as to develop specific clinical management protocols and further research and development (R & D) for therapeutics.

For this purpose, a central database of clinical and laboratory parameters of hospitalised COVID-19 cases is being created. All hospitals currently managing COVID-19 patients are invited to become partners in the network.

Meanwhile, hospitals should continue to independently report the concerned data to Central/State health authorities as per the current guidelines, according to the ICMR.

In a letter, Dr Balram Bhargava, Director General of ICMR, said: "The national task force for COVID-19 has constituted the research groups to identify the research priorities and quickly initiate research studies. This group includes clinical research group, research on diagnostics and biomarkers, epidemiology and surveillance, operations research, vaccine/drug research, and development."

The chairs of these groups will convene meetings of respective groups through video conference to identify research priorities, develop research protocols and identify partners institutes for initiating studies, Dr Bhargava said in the letter, a copy of which is with ANI.

The letter discussed the TOR for each group which has a focus to -- identify research priorities, review evidence, align them in consonance with the current level of response, identify protocols and partners for implementation.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 07 2020 | 10:18 PM IST

Next Story